APACHE II expected outcome calculations are subject to inter-observer variation. Go to Publication You Might Also Like Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection August 30, 2019 Safety and efficacy of thioridazine as salvage therapy in Indian patients with XDR-TB. May 3, 2011 A 24-year-old man with giddiness, hemoptysis, and skin lesions. November 13, 2008 Clofazimine: an old drug for never-ending diseases September 3, 2020 Xpert MTB/RIF and pulmonary tuberculosis: time to delve deeper? November 24, 2013
Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection August 30, 2019